01
Health financing and insurance
Insurance design, actuarial analysis, benefit-package costing and strategic purchasing for governments and insurers moving towards universal health coverage with less external funding.
Health economics & health financing · Kigali · Addis Ababa
Local, validated health economic evidence for African health systems — delivered in weeks, not months.
Actuarial, health financing and HTA expertise in one African team, with academic depth at consultancy speed. We support governments, insurers, development partners and global HEOR firms across sub-Saharan Africa.
Practice areas
Two flagship practice areas
Health financing and insurance, and economic evaluation and HTA — with costing running across both, and supporting services that complete the evidence.
02
Economic evaluation and health technology assessment
Cost-effectiveness and budget impact analysis, local adaptation of published models, and support to health technology assessment processes and benefit-package committees.
Why HEOR Africa
Built for the decisions African health systems face now
Actuarial and HTA expertise in one African team
Benefit packages, premiums, tariffs and cost-effectiveness are designed together — the way insurers and benefit committees need them.
Academic depth at consultancy speed
University faculty in health economics set the methods and sign off the evidence; project managers deliver to fixed timelines.
Local evidence, global standards
Local costs, data and decision processes, delivered with reproducible code, independent quality control and CHEERS 2022 reporting.
Two hubs, one team
From Kigali and Addis Ababa we work across East Africa, the Horn of Africa and the wider sub-Saharan region.
Where we work:Sub-Saharan AfricaEast AfricaEthiopiaRwanda
Method
How we work
Every engagement — an actuarial study, an economic evaluation or an impact evaluation — runs through the same reproducible pipeline, with three points where a senior expert must sign off before work moves on.
- 1
Scoping
Agree the decision, the questions to answer, the population and the methods.
Sign-off gate 1: Scope and analysis plan
A senior health economist signs off the scope and analysis plan or model structure before evidence work begins.
- 2
Evidence
Identify and appraise clinical, epidemiological and economic evidence in a documented search.
- 3
Local inputs
Source local costs, resource use, epidemiology and programme data, each traced to a cited source.
Sign-off gate 2: Inputs and sources
A clinical or subject-matter expert signs off the parameter table and its sources.
- 4
Modelling and analysis
Build the model or analysis in R, with version-controlled, reviewable code.
- 5
Independent QC
A second analyst checks code, inputs and outputs against a written checklist.
Sign-off gate 3: Results and interpretation
Results and their interpretation are signed off before anything is released.
- 6
Reporting
A CHEERS 2022-aligned report, parameter table and briefing for decision-makers.
Every parameter has a source
Inputs are recorded in a parameter table with their source, justification and range.
Reproducible by design
Models are built in R under version control, so any result can be regenerated.
Independently checked
A second analyst checks each model before results are released, and reporting follows CHEERS 2022.
Featured insight
All insights2 min read
Adding an economic evaluation aim to your grant proposal
How to add a clear, fundable economic evaluation aim to a research or programme grant, with example wording, design choices and budget lines.
Tags: economic evaluation · grants · methods
Have a decision that needs local evidence?
Tell us what you need and we will reply within one business day with next steps — or book a 20-minute call.